Click here to learn about Academy events, publications and initiatives around COVID-19.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Our site is under planned maintenance. At this time, you will not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.


Special Issue: Myasthenia Gravis and Related Disorders I

Edited by

Ann NY Acad Sci editorial staff

Special Issue: Myasthenia Gravis and Related Disorders I

Published: January 2018

Volume 1412

Published since 1824, Annals of the New York Academy of Sciences is the Academy’s premier scientific publication.

Learn More


Learning from the past: reflections on recently completed myasthenia gravis trials

Michael Benatar, James F. Howard Jr., Richard Barohn, Gil I. Wolfe, Gary Cutter



A unique subphenotype of myasthenia gravis

Jeannine M. Heckmann, Melissa Nel



AIRE: a missing link to explain female susceptibility to autoimmune diseases

Sonia Berrih‐Aknin, Rozen Le Panse, Nadine Dragin

Circulating microRNAs as potential biomarkers in myasthenia gravis patients

Anna Rostedt Punga, Tanel Punga

Age‐related changes in the structure and function of mammalian neuromuscular junctions

Silvia Willadt, Mark Nash, Clarke Slater

The mouse passive‐transfer model of MuSK myasthenia gravis: disrupted MuSK signaling causes synapse failure

Nazanin Ghazanfari, Sofie Trajanovska, Marco Morsch, Simon X. Liang, Stephen W. Reddel, William D. Phillips

The molecular cross talk of the dystrophin–glycoprotein complex

Marta Gawor, Tomasz J. Prószyński

Lambert–Eaton myasthenic syndrome: mouse passive‐transfer model illuminates disease pathology and facilitates testing therapeutic leads

Stephen D. Meriney, Tyler B. Tarr, Kristine S. Ojala, Man Wu, Yizhi Li, David Lacomis, Adolfo Garcia‐Ocaña, Mary Liang, Guillermo Valdomir, Peter Wipf

Myasthenia gravis with antibodies to MuSK: an update

Amelia Evoli, Paolo E. Alboini, Valentina Damato, Raffaele Iorio, Carlo Provenzano, Emanuela Bartoccioni, Mariapaola Marino



Diagnostic utility of cortactin antibodies in myasthenia gravis

Isabel Illa, Elena Cortés‐Vicente, María Ángeles Martínez, Eduard Gallardo

Developing treatment guidelines for myasthenia gravis

Donald B. Sanders, Gil I. Wolfe, Pushpa Narayanaswami, the MGFA Task Force on MG Treatment Guidance

Clinical and research strategies for limb‐girdle congenital myasthenic syndromes

Emily O'Connor, Ana Töpf, René P. Zahedi, Sally Spendiff, Daniel Cox, Andreas Roos, Hanns Lochmüller

Myasthenia gravis: the role of complement at the neuromuscular junction

James F. Howard Jr.

Therapeutic strategies for congenital myasthenic syndromes

Manon Lee, David Beeson, Jacqueline Palace

Thymus involvement in early‐onset myasthenia gravis

Mélanie A. Cron, Solène Maillard, José Villegas, Frédérique Truffault, Muriel Sudres, Nadine Dragin, Sonia Berrih‐Aknin, Rozen Le Panse

Neuromuscular synapse electrophysiology in myasthenia gravis animal models

Jaap J. Plomp, Maartje G.M. Huijbers, Jan J.G.M. Verschuuren

Mechanisms underlying B cell immune dysregulation and autoantibody production in MuSK myasthenia gravis

Panos Stathopoulos, Aditya Kumar, Jason A. Vander Heiden, Elba Pascual‐Goñi, Richard J. Nowak, Kevin C. O'Connor



The Association of British Neurologists' myasthenia gravis guidelines

Jon Sussman, Maria E. Farrugia, Paul Maddison, Marguerite Hill, M. Isabel Leite, David Hilton‐Jones

Homeostatic synaptic plasticity at the neuromuscular junction in myasthenia gravis

Xueyong Wang, Mark M. Rich

Funding for this publication was made possible (in part) by 1R13NS101926-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.